Elizabeth Yarber
Senior Director of Clinical Operations @ AOA Dx
About Elizabeth Yarber
Elizabeth Yarber is a Senior Director of Clinical Operations specializing in the management of clinical trials across various therapeutic areas, with a strong focus on quality and regulatory oversight.
Known information
Elizabeth Yarber serves as the Senior Director of Clinical Operations, where she specializes in overseeing clinical operations, quality, and regulatory aspects of global clinical trials in biopharmaceuticals, medical devices, and diagnostics. With extensive experience in all phases of clinical trials, she has played a pivotal role in achieving market access for strategic business initiatives. Elizabeth is certified in Project Management by PMI and has a robust approach to risk and quality management throughout the clinical trial process, from development to regulatory approval. She holds an undergraduate degree in Organizational Leadership and a Master of Science in Health Outcomes Research from St. Louis University.
About AOA Dx
AOA Dx, headquartered in New York, NY, and Cambridge, MA, is a healthcare company specializing in early cancer detection technologies, particularly focusing on ovarian cancer through innovative blood tests like GlycoLocate™ and AKRIVIS GD™.